Subcortical and cortical structural central nervous system changes and attention processing deficits in preschool-aged children with prenatal methamphetamine and tobacco exposure.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 4091037)

Published in Dev Neurosci on August 17, 2012

Authors

Chris Derauf1, Barry M Lester, Nurunisa Neyzi, Minal Kekatpure, Luis Gracia, James Davis, Kalpana Kallianpur, Jimmy T Efird, Barry Kosofsky

Author Affiliations

1: Mayo Clinic, Rochester, MN 55905, USA. derauf.donald@mayo.edu

Articles cited by this

Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage (1999) 40.38

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron (2002) 33.99

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52

Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A (2000) 19.87

High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp (1999) 16.32

Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging (2001) 8.14

Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA (2001) 4.84

Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage (2001) 4.52

Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA (2000) 4.49

Effects of age on volumes of cortex, white matter and subcortical structures. Neurobiol Aging (2005) 3.63

Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants. Pediatrics (2003) 3.09

Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet (2003) 2.71

The cognitive functions of the caudate nucleus. Prog Neurobiol (2008) 2.66

Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex (2006) 2.44

Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci (2009) 2.33

Typologies of attentional networks. Nat Rev Neurosci (2006) 2.19

The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics (2006) 1.98

Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD. Am J Psychiatry (2007) 1.96

Clinical, imaging, lesion, and genetic approaches toward a model of cognitive control. Dev Psychobiol (2002) 1.92

Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol (2007) 1.90

Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J (2006) 1.81

Smoking and structural brain deficits: a volumetric MR investigation. Eur J Neurosci (2006) 1.80

Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res (2004) 1.78

Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiatry (2006) 1.70

Abnormal cortical thickness and brain-behavior correlation patterns in individuals with heavy prenatal alcohol exposure. Cereb Cortex (2007) 1.69

Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med (2005) 1.68

Clinical utility of the Test of Variables of Attention (TOVA) in the diagnosis of attention-deficit/hyperactivity disorder. J Clin Psychol (1998) 1.67

Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci (2010) 1.62

Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol (2003) 1.59

Third pathophysiology of prenatal cocaine exposure. Dev Neurosci (2009) 1.56

Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. Neuropsychopharmacology (2007) 1.54

Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics (2009) 1.52

Neuroimaging and fetal alcohol spectrum disorders. Dev Disabil Res Rev (2009) 1.51

Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana. Pediatrics (2008) 1.51

Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol Med (2001) 1.49

Developmental consequences of prenatal tobacco exposure. Curr Opin Neurol (2009) 1.37

Prenatal exposure to maternal cigarette smoking and the adolescent cerebral cortex. Neuropsychopharmacology (2007) 1.33

Effects of heavy in utero cocaine exposure on adolescent caudate morphology. Pediatr Neurol (2007) 1.25

Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice. Neuroscience (2006) 1.23

Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol (2010) 1.22

Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr (2010) 1.21

Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction. Addiction (2007) 1.20

Neuroimaging of children following prenatal drug exposure. Semin Cell Dev Biol (2009) 1.17

Abnormal cortical thickness alterations in fetal alcohol spectrum disorders and their relationships with facial dysmorphology. Cereb Cortex (2011) 1.15

Conceptual, methodological, and statistical challenges in brain imaging studies of developmentally based psychopathologies. Dev Psychopathol (2003) 1.12

Differentiating prenatal exposure to methamphetamine and alcohol versus alcohol and not methamphetamine using tensor-based brain morphometry and discriminant analysis. J Neurosci (2010) 1.12

Developmental cortical thinning in fetal alcohol spectrum disorders. Neuroimage (2011) 1.09

Cortical gray matter in attention-deficit/hyperactivity disorder: a structural magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry (2010) 1.05

Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics (2012) 1.03

Age does not increase rate of forgetting over weeks--neuroanatomical volumes and visual memory across the adult life-span. J Int Neuropsychol Soc (2005) 1.00

Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol (2011) 1.00

Gray matter volume reduction in rostral middle frontal gyrus in patients with chronic schizophrenia. Schizophr Res (2010) 1.00

Fetal effects of psychoactive drugs. Clin Perinatol (2009) 0.99

Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesis. Brain Res Brain Res Rev (2000) 0.98

Prenatal methamphetamine exposure and inhibitory control among young school-age children. J Pediatr (2012) 0.87

Diffusion tensor imaging studies of prenatal drug exposure: challenges of poly-drug use in pregnant women. J Pediatr (2011) 0.76

Articles by these authors

Smoking during pregnancy and newborn neurobehavior. Pediatrics (2003) 2.93

The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci (2008) 2.72

Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum Gene Ther (2008) 2.42

FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest (2012) 2.41

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend (2005) 2.26

The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics (2006) 1.98

Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol (2007) 1.90

Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci U S A (2003) 1.86

The association of methamphetamine use and cardiomyopathy in young patients. Am J Med (2007) 1.70

Novel extracellular matrix structures in the neural stem cell niche capture the neurogenic factor fibroblast growth factor 2 from the extracellular milieu. Stem Cells (2007) 1.67

Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV. Antivir Ther (2012) 1.64

The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics (2004) 1.61

Regional brain morphometry and impulsivity in adolescents following prenatal exposure to cocaine and tobacco. JAMA Pediatr (2013) 1.61

Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PLoS One (2012) 1.58

Impact of prenatal exposure to cocaine and tobacco on diffusion tensor imaging and sensation seeking in adolescents. J Pediatr (2011) 1.53

Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol (2005) 1.52

Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making? J Thorac Cardiovasc Surg (2013) 1.49

Longitudinal study of maternal report of sleep problems in children with prenatal exposure to cocaine and other drugs. Behav Sleep Med (2009) 1.42

Protective effects of dietary antioxidants on proton total-body irradiation-mediated hematopoietic cell and animal survival. Radiat Res (2009) 1.31

Assessment of infant cry: acoustic cry analysis and parental perception. Ment Retard Dev Disabil Res Rev (2005) 1.30

Ion-controlled conformational dynamics in the outward-open transition from an occluded state of LeuT. Biophys J (2012) 1.30

Normative neurobehavioral performance of healthy infants on the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics (2004) 1.24

Prenatal cocaine use and maternal depression: effects on infant neurobehavior. Neurotoxicol Teratol (2006) 1.22

Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol (2010) 1.22

Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr (2010) 1.21

Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade. J Pharmacol Exp Ther (2007) 1.20

Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men. J Acquir Immune Defic Syndr (2004) 1.18

Neuroimaging of children following prenatal drug exposure. Semin Cell Dev Biol (2009) 1.17

Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J (2009) 1.16

Behavioral epigenetics. Ann N Y Acad Sci (2011) 1.14

Functional MRI and response inhibition in children exposed to cocaine in utero. Preliminary findings. Dev Neurosci (2009) 1.14

Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS (2009) 1.12

A family and community focused lifestyle program prevents weight regain in Pacific Islanders: a pilot randomized controlled trial. Health Educ Behav (2011) 1.12

Sleep problems in children with prenatal substance exposure: the Maternal Lifestyle study. Arch Pediatr Adolesc Med (2010) 1.12

Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance. J Pharmacol Exp Ther (2007) 1.11

Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study. Ther Drug Monit (2009) 1.10

Three-dimensional high-resolution diffusion tensor imaging and tractography of the developing rabbit brain. Dev Neurosci (2007) 1.10

Parenting intervention for externalizing behavior problems in children born premature: an initial examination. J Dev Behav Pediatr (2010) 1.10

Dietary antioxidants protect hematopoietic cells and improve animal survival after total-body irradiation. Radiat Res (2008) 1.09

The combined effects of prenatal drug exposure and early adversity on neurobehavioral disinhibition in childhood and adolescence. Dev Psychopathol (2011) 1.09

The influence of community and individual health literacy on self-reported health status. J Gen Intern Med (2013) 1.09

Predictors of motor development in children prenatally exposed to cocaine. Neurotoxicol Teratol (2004) 1.09

Antihypertensive adherence and drug class among Asian Pacific Americans. Ethn Health (2007) 1.08

Western Trauma Association critical decisions in trauma: nonoperative management of adult blunt hepatic trauma. J Trauma (2009) 1.07

Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine. Neurotoxicol Teratol (2008) 1.07

Epidemiologic and clinical factors associated with chronic kidney disease among Asian Americans and Native Hawaiians. Ethn Health (2007) 1.06

Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). Am J Drug Alcohol Abuse (2007) 1.05

Placenta-imprinted gene expression association of infant neurobehavior. J Pediatr (2011) 1.05

Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med (2007) 1.04

Patterning in placental 11-B hydroxysteroid dehydrogenase methylation according to prenatal socioeconomic adversity. PLoS One (2013) 1.03

The effect of parenting stress on child behavior problems in high-risk children with prenatal drug exposure. Child Psychiatry Hum Dev (2008) 1.03

Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics (2012) 1.03

Global and gene-specific DNA methylation across multiple tissues in early infancy: implications for children's health research. FASEB J (2014) 1.02

Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis. Hum Gene Ther Methods (2012) 1.01

Fifteen-year experience with minimally invasive approach for reoperations involving the mitral valve. J Thorac Cardiovasc Surg (2011) 1.01

Atypical cry acoustics in 6-month-old infants at risk for autism spectrum disorder. Autism Res (2012) 1.00

Cultivating engaged leadership through a learning collaborative: lessons from primary care renewal in Oregon safety net clinics. Ann Fam Med (2013) 1.00

Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol (2011) 1.00

Teaching and learning evidence-based medicine in complementary, allied, and alternative health care: an integrated tailor-made course. J Altern Complement Med (2007) 0.99

Fetal effects of psychoactive drugs. Clin Perinatol (2009) 0.99

Interactions between maternal characteristics and neonatal behavior in the prediction of parenting stress and perception of infant temperament. J Pediatr Psychol (2005) 0.99

Socioeconomic disparities in breast cancer screening in Hawaii. Prev Chronic Dis (2007) 0.99

Vagal tone as a resilience factor in children with prenatal cocaine exposure. Dev Psychopathol (2007) 0.98

The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age. Am J Perinatol (2011) 0.98

Self identity through Ho'oponopono as adjunctive therapy for hypertension management. Ethn Dis (2007) 0.98

Violence and delinquency, early onset drug use, and psychopathology in drug-exposed youth at 11 years. Ann N Y Acad Sci (2006) 0.97

Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia. Cancer Res (2004) 0.97

Importance of stability of early living arrangements on behavior outcomes of children with and without prenatal drug exposure. J Dev Behav Pediatr (2008) 0.97

Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med (2008) 0.97

Followup after an emergency department visit for asthma: urban/rural patterns. Ethn Dis (2008) 0.96

Small for gestational age and higher birth weight predict childhood obesity in preterm infants. Am J Perinatol (2010) 0.96

Colorectal cancer screening: low health literacy and limited English proficiency among Asians and Whites in California. J Health Commun (2013) 0.96

Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress Anxiety (2011) 0.96

Impact of race and postoperative atrial fibrillation on long-term survival after coronary artery bypass grafting. J Card Surg (2013) 0.96

Clinical use of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics (2004) 0.95

Is evidence-based medicine teaching and learning directed at improving practice? J R Soc Med (2010) 0.94

Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women. AIDS (2013) 0.93

Missed well-child care visits, low continuity of care, and risk of ambulatory care-sensitive hospitalizations in young children. Arch Pediatr Adolesc Med (2010) 0.92

Approaching intelligent infection diagnostics: Carbon fibre sensor for electrochemical pyocyanin detection. Bioelectrochemistry (2009) 0.91

Placental HTR2A methylation is associated with infant neurobehavioral outcomes. Epigenetics (2013) 0.91

Comparison of motor self-regulatory and stress behaviors of preterm infants across body positions. Am J Occup Ther (2003) 0.91

Cathodic reduction of bisulfite and sulfur dioxide in aqueous solutions on copper electrodes: an electrochemical ESR study. J Phys Chem B (2005) 0.91

Long-term study of bone remodelling after femoral stem: a comparison between dexa and finite element simulation. J Biomech (2007) 0.91

Manganese detection in marine sediments: anodic vs. cathodic stripping voltammetry. Talanta (2005) 0.91

The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats. Eur J Pharmacol (2009) 0.90

Use of the dietary supplement 5-aminiolevulinic acid (5-ALA) and its relationship with glucose levels and hemoglobin A1C among individuals with prediabetes. Clin Transl Sci (2012) 0.90

Acute ethanol intoxication and the trauma patient: hemodynamic pitfalls. World J Surg (2011) 0.90

Major depressive disorder during pregnancy and emotional attachment to the fetus. Arch Womens Ment Health (2011) 0.89

Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation. J Am Heart Assoc (2014) 0.89

Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats. Toxicol Sci (2007) 0.89

Growth trajectories of preterm infants: birth to 12 years. J Pediatr Health Care (2008) 0.88

Serial pediatric symptom checklist screening in children with prenatal drug exposure. J Dev Behav Pediatr (2011) 0.88

Preoperative atrial fibrillation and long-term survival after open heart surgery in a rural tertiary heart institute. Heart Lung (2013) 0.88

Factors Affecting Sustained Medication Adherence and Its Impact on Health Care Utilization in Patients with Diabetes. J Pharm Health Serv Res (2013) 0.88